NASDAQ: NHPNational Healthcare Properties Inc Stock
$13.98-0.11 (-0.78%)
Updated Jun 10, 2026
NHP Price
$13.98
Fair Value Price
N/A
Market Cap
$400.25M
52 Week Low
$11.25
52 Week High
$15.40
P/E
-5.38x
P/B
0.68x
P/S
N/A
PEG
N/A
Dividend Yield
3.3%
Revenue
$342.12M
Earnings
-$60.36M
Gross Margin
27.9%
Operating Margin
0.38%
Profit Margin
-21.5%
Debt to Equity
1.86
Operating Cash Flow
$37M
Beta
-0.22
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
NHP Overview
National Healthcare Properties, Inc. (NHP) operates as a real estate investment trust (REIT), concentrating its efforts on acquiring, owning, and overseeing a varied portfolio of properties within the healthcare industry. The company's activities are organized into two primary divisions: Outpatient Medical Facilities (OMF) and Senior Housing Operating Properties (SHOP). The OMF segment covers an array of facilities, including senior living developments, hospitals, inpatient rehabilitation centers, and skilled nursing facilities, which are all leased to various healthcare-related entities via long-term agreements. In contrast, the SHOP segment involves direct equity investments in senior housing communities. These locations predominantly offer services such as assisted living, independent living, and specialized memory care, with their daily operations managed by independent third-party firms. NHP was founded on October 15, 2012, and its corporate headquarters are situated in New York, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine NHP's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Healthcare Facility REIT
Industry Rating
D
NHP
Ranked#4 of 17
Ranked#4 of 17
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $13.24 | B | |
| $17.86 | C | |
| $20.47 | C |
Be the first to know about important NHP news, forecast changes, insider trades & much more!
NHP News
Overview
Due Diligence Score
–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NHP scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
NHP is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NHP is good value based on its book value relative to its share price (0.68x), compared to the US REIT - Healthcare Facilities industry average (2.71x)
P/B vs Industry Valuation
NHP is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more NHP due diligence checks available for Premium users.
Valuation
NHP price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-5.38x
Industry
89.91x
Market
14.77x
NHP price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.68x
Industry
2.71x
NHP is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
NHP's financial health
Profit margin
Revenue
$86.3M
Net Income
-$4.3M
Profit Margin
-8.8%
NHP's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.7B
Liabilities
$1.1B
Debt to equity
1.86
NHP's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
NHP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$9.0M
Investing
-$5.4M
Financing
-$5.4M
NHP vs Healthcare Facility REIT Stocks
National Healthcare Properties Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.